company background image
530317 logo

Godavari Drugs BSE:530317 Stock Report

Last Price

₹102.10

Market Cap

₹765.5m

7D

-4.3%

1Y

8.3%

Updated

23 Jul, 2024

Data

Company Financials

Godavari Drugs Limited

BSE:530317 Stock Report

Market Cap: ₹765.5m

530317 Stock Overview

Manufactures and supplies active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India.

530317 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health3/6
Dividends0/6

Godavari Drugs Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Godavari Drugs
Historical stock prices
Current Share Price₹102.10
52 Week High₹114.00
52 Week Low₹82.10
Beta0.94
11 Month Change2.81%
3 Month Change1.61%
1 Year Change8.32%
33 Year Change32.17%
5 Year Change438.79%
Change since IPO3,247.54%

Recent News & Updates

Recent updates

Shareholder Returns

530317IN PharmaceuticalsIN Market
7D-4.3%-0.6%-1.5%
1Y8.3%47.4%43.8%

Return vs Industry: 530317 underperformed the Indian Pharmaceuticals industry which returned 47.4% over the past year.

Return vs Market: 530317 underperformed the Indian Market which returned 43.8% over the past year.

Price Volatility

Is 530317's price volatile compared to industry and market?
530317 volatility
530317 Average Weekly Movement3.1%
Pharmaceuticals Industry Average Movement5.6%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.7%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 530317 has not had significant price volatility in the past 3 months.

Volatility Over Time: 530317's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1987104Mukund Kakanigodavaridrugs.com

Godavari Drugs Limited manufactures and supplies active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. It offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. The company also provides loan license and contract manufacturing services.

Godavari Drugs Limited Fundamentals Summary

How do Godavari Drugs's earnings and revenue compare to its market cap?
530317 fundamental statistics
Market cap₹765.48m
Earnings (TTM)₹55.49m
Revenue (TTM)₹1.57b

13.9x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
530317 income statement (TTM)
Revenue₹1.57b
Cost of Revenue₹1.21b
Gross Profit₹365.19m
Other Expenses₹309.70m
Earnings₹55.49m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)7.37
Gross Margin23.21%
Net Profit Margin3.53%
Debt/Equity Ratio142.8%

How did 530317 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.